<DOC>
	<DOCNO>NCT00306410</DOCNO>
	<brief_summary>The purpose study determine effect normalization vitamin D level bone density , immune adipocyte function HIV1-seropositive patient .</brief_summary>
	<brief_title>The Prevalence Vitamin D Deficiency Effects Vitamin D Supplementation HIV-1 Infected Patients</brief_title>
	<detailed_description>Vitamin D deficiency common , especially black , HIV-seropositive patient . Vitamin D deficiency cause lack sunlight and/or insufficient vitamin D intake via diet . The HIV infection antiretroviral therapy ( ART ) may also cause vitamin D deficiency . ART interfere cytochrome p450 activity might affect vitamin D metabolism . Vitamin D several important physiological function 1. regulation calcium phosphate homeostasis , 2. immunomodulatory property 3. effect adipocyte differentiation . Low vitamin D level lead decrease bone mineralization , eventually result rachitis ( child ) osteomalacia ( adult ) . In addition vitamin D deficiency lead secondary hyperparathyroidism , lead even bone matrix demineralization . In HIV infect person overall prevalence osteopenia osteoporoses 14-84 % 0-45 % respectively . Vitamin D suggest play role HIV-associated bone disorder . The vitamin D status also affect host defence HIV patient ; significantly low CD4 cell count find patient 1,25 ( OH ) vitamin D deficiency . Furthermore , influence vitamin D adipocyte differentiation effect HAART vitamin D level might relevant change fat distribution development insulin resistance see day initiation HAART . Vitamin D metabolize body trough cytochrome P450 enzyme . HAART might interact vitamin D metabolism basis CYP3A4 , play important role clearance antiretroviral agent also show vitamin D 24 25-hydroxylase vitro . We hypothesize PI ’ lead low 1a,25 ( OH ) 2D3 suppress 1a- 25-hydroxylase activity . The result pilot show 25 ( OH ) D deficiency common among HIV patient . Seen diversity function vitamin D , hypothesize ’ beneficial patient normal vitamin D status . Therefore , supplementation vitamin D warrant . In study want investigate , despite complex interaction HAART/ HIV vitamin D metabolism , supplementation colecalciferol ( 2000 IU daily ) lead normalization vitamin D level . Furthermore , want study effect normalization vitamin D level bone mineral density , immune adipocyte function . Therefore prospective , randomize , double-blind , placebo-controlled vitamin D intervention study vitamin D deficient HIV1-seropositive patient .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>&gt; 18 jr able give inform consent HIV seropositive diagnose standard technique Hypovitaminoses D Hypercalcemia : calcium level &gt; 2.60 mmol/L Renal disorder : serum creatinine &gt; 2 time Upper limit normal ( ULN ) ( 110 mmol/l ) Liver disorder ; elevation ASAT ALAT &gt; 5 x ULN . The ULNs 40 IU/L 45 IU/L ASAT ALAT , respectively . Pregnancy Drug alcohol abuse Non compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Vitamin D deficiency</keyword>
	<keyword>HIV/AIDS</keyword>
	<keyword>HAART</keyword>
	<keyword>T-Lymphocytes , Regulatory</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>bone density</keyword>
</DOC>